Acción 000919 JINLING PHARMACEUTICAL COMPANY LIMITED
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Jinling Pharmaceutical Company Limited

Acciones

000919

CNE0000010W5

Precio de cierre Shenzhen S.E.
Otros sitios de cotización
 00:00:00 17/06/2024 		Varia. Cinco días. Varia. 1 de enero.
6,5 CNY -0,31 % Gráfico intradía de Jinling Pharmaceutical Company Limited -0,46 % -17,41 %
29/04 Jinling Pharmaceutical Company Limited presenta los resultados del primer trimestre finalizado el 31 de marzo de 2024 CI
18/04 Jinling Pharmaceutical Company Limited informa de los resultados de ganancias para el año completo finalizado el 31 de diciembre de 2023 CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!
Inscripción 100% Gratuita
Hefei Jinling Tianyi Smart Elderly Care Services Co., Ltd. announced that it has received CNY 600 million in funding from Jinling Pharmaceutical Company Limited
Jinling Pharmaceutical Company Limited Announces Final Dividend on A Shares for the Year 2023, Payable on 31 May 2024
Jinling Pharmaceutical Company Limited Approves Cash Dividend for the Year 2023
Jinling Pharmaceutical Company Limited Proposes Final Cash Dividend for the Year 2023
Jinling Pharmaceutical Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024
Hefei Jinling Tianyi Smart Elderly Care Services Co., Ltd. announced that it expects to receive CNY 600 million in funding from Jinling Pharmaceutical Company Limited
Jinling Pharmaceutical Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023
Jinling Pharmaceutical Company Limited announced that it has received CNY 749.999998 million in funding from a group of investors
Jinling Pharma in Talks to Buy Over 50% Stake in Local Hospital
Jinling Pharmaceutical Company Limited agreed to acquire 43.6% stake in Nanjing Meishan Hospital Co., Ltd. from Nanjing New Industrial Investment Group Co.,Ltd. and Nanjing Zijin Investment Management Co., Ltd.
Jinling Pharmaceutical Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2023
Jinling Pharmaceutical Company Limited Reports Earnings Results for the Half Year Ended June 30, 2023
Jinling Pharma Selling 750 Million Yuan Shares to Fund New Projects
Jinling Pharmaceutical Company Limited Announces 2022 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on 14 July 2023
Jinling Pharmaceutical Company Limited Approves Management Appointments
Jinling Pharmaceutical Company Limited Approves Cash Dividend for the Year 2022
Jinling Pharmaceutical Vice Chairman Resigns
Jinling Pharmaceutical Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2023
Jinling Pharmaceutical Company Limited Proposes Final Cash Dividend for the Year 2022
Jinling Pharmaceutical Company Limited announced that it expects to receive CNY 750 million in funding from Nanjing New Industrial Investment Group Co., Ltd and other investors
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción 000919
  4. Noticias Jinling Pharmaceutical Company Limited
  5. Otros idiomas